Main > ONCOLOGY (**) > Lymphoma>NHL>B-Cell>MCL R > Treatment > Co: UK. A. Brand Acalabrutinib>

---

Co: UK. A. Brand Acalabrutinib>'s subsections
(*) CA Approval Date: 2019. 10.08.
(*) USA Approval Date: 2017. 10.31
>Received One Prior Therapy
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2019. 04.30
TradeMark
TradeMark Web-Site

Co: UK. A. Brand Acalabrutinib>'s products
This section has no products